EE53 The Net Monetary Benefit of Introducing Sodium-Glucose Cotransporter-2 Inhibitors in Middle-Income Countries.
Saved in:
| Title: | EE53 The Net Monetary Benefit of Introducing Sodium-Glucose Cotransporter-2 Inhibitors in Middle-Income Countries. |
|---|---|
| Authors: | Falavigna, M1 (AUTHOR), Deyneli, O2 (AUTHOR), Seyam, A3 (AUTHOR), Mustafa, N4 (AUTHOR), Giorgi, M5 (AUTHOR), Gabriel, Z6 (AUTHOR), Goncalves, S7 (AUTHOR), Solorzano, J8 (AUTHOR), Vasnawala, H9 (AUTHOR), Schabert, V10 (AUTHOR), Mihajlović, J11 (AUTHOR) |
| Source: | Value in Health. 2022 Suppl, Vol. 25 Issue 12, pS63-S63. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2022.09.306 |
